Stand Up To Cancer, also known as SU2C, is a privately owned entity headquartered in the US that functions as a tier 2 media tech buyer. Founded in 2008, the organization has approximately 60 employees and reported $38.1M in revenue as of 2023. The company's main product involves content rights, and its mission focuses on raising funds to accelerate groundbreaking translational research to develop new therapies for patients and save lives.
A mailed fecal immunochemical test (FIT)-DNA outreach program demonstrated increased participation rates for colorectal cancer (CRC) screening at 90 and 180 days compared to a mailed FIT approach in community health centers on June 10, 2026; however, timely completion of colonoscopy after abnormal tests remained low even with navigation support. Previously, "Survivor" fans raised a record amount for Stand Up To Cancer with a live finale giveaway and auction of season 50 items on May 20, 2026, highlighting the show's broader involvement with the organization. This followed AbbVie's announcement on March 27, 2026, of a multi-year partnership with Major League Baseball (MLB), naming AbbVie the Official Pharmaceutical Partner of MLB beginning with the 2026 season and marking the national expansion of "Striking Out Cancer," initially introduced with the Chicago Cubs in the 2025 MLB season. On January 8, 2026, Stand Up To Cancer (SU2C) and Cancer Research UK announced new support for a global dream team to launch a clinical trial focused on preventing gastric cancer in its earliest stages.
Similar Companies
Subscribe for full access to Stand Up To Cancer's profile
Stand Up To Cancer offers products in the media and telecoms services industry. Stand Up To Cancer's product portfolio comprises of entertainment content rights.
Subscribe for full access to Stand Up To Cancer's products in full detail
Stand Up To Cancer's revenues were less than $50M in 2024. All the revenue comes from entertainment rights and distribution.
Subscribe for full access to Stand Up To Cancer's revenue in full detail
Subscribe for full access to Stand Up To Cancer's products in full detail 
